Australia's #1 directory for medical equipment & suppliers

Boucher & Muir

Pharmaceutical & Medical Supplies

Basic Profile
Follow
3 Followers
Boucher & Muir Pty Ltd was incorporated as a company in 1957. From 1957 to 1964, Boucher & Muir Pty Ltd was intimately involved in the supply of pharmaceuticals and hospital products to the
Read more |Promo message
Promo message

As we gained experience in delivering pharmaceuticals and other medical supplies to the Pacific nations, we developed exclusive distribution relationships with a host of suppliers based in Australia, Europe and South-East Asia.

The growth of the export market saw a dilution of our business interest in Australia. However, the registration of a number of products in Australia has provided renewed interest in the Australian domestic market. An expansion strategy has been put in place to further develop the Australian market with the potential introduction of niche products in the near future.

The growth in the export market opened distribution opportunities for Boucher & Muir. Through its knowledge and long experience in the Pacific market, a number of exclusive distribution agreements have been negotiated. Some of the distribution agreements include:

* Vaccines manufactured by CSL (Australia) & Aventis Pasteur
* Biochemie/Sandoz products in the public markets of the Pacific nations
* Pharmaceuticals manufactured by Rotexmedica GmbH based in Germany
* TYCO Healthcare

Hide promo message

About Boucher & Muir

Boucher & Muir Pty Ltd was incorporated as a company in 1957. From 1957 to 1964, Boucher & Muir Pty Ltd was intimately involved in the supply of pharmaceuticals and hospital products to the Commonwealth and various state governments in Australia. During this period, Boucher & Muir Pty Ltd held substantial contracts for the supply of pharmaceuticals on tenders.

In 1964, the first major opportunity arose to supply pharmaceuticals to the Department of Health in Papua New Guinea. Following this initial success, Boucher & Muir Pty Ltd slowly began to grow its export market by introducing new high quality cost-effective suppliers and establishing supply routes to cover a host of Pacific nation governments including Fiji, Samoa, Tonga, Solomon Islands, Vanuatu and Kiribati.

Boucher & Muir has registered the following products for sale in Australia:

* Primacin tablets containing 7.5mg primaquine base
* Melleril tablets containing 25mg imipramine HCl
* Optycin eye ointment containing 1% tetracycline HCl

Promo message Boucher & Muir

As we gained experience in delivering pharmaceuticals and other medical supplies to the Pacific nations, we developed exclusive distribution relationships with a host of suppliers based in Australia, Europe and South-East Asia.

The growth of the export market saw a dilution of our business interest in Australia. However, the registration of a number of products in Australia has provided renewed interest in the Australian domestic market. An expansion strategy has been put in place to further develop the Australian market with the potential introduction of niche products in the near future.

The growth in the export market opened distribution opportunities for Boucher & Muir. Through its knowledge and long experience in the Pacific market, a number of exclusive distribution agreements have been negotiated. Some of the distribution agreements include:

* Vaccines manufactured by CSL (Australia) & Aventis Pasteur
* Biochemie/Sandoz products in the public markets of the Pacific nations
* Pharmaceuticals manufactured by Rotexmedica GmbH based in Germany
* TYCO Healthcare